Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta

Autor: Collins, SL, Alemdar, B, van Beekhuizen, Heleen, Bertholdt, C, Braun, T, Calda, P, Delorme, P, Duvekot, J.J., Gronbeck, L, Kayem, G, Langhoff-Roos, J, Marcellin, L, Martinelli, P, Morel, O, Mhallem, M, Morlando, M, Noergaard, LN, Nonnenmacher, A, Pateisky, P, Petit, P, Rijken, MJ, Ropacka-Lesiak, M, Schlembach, D, Sentilhes, L, Stefanovic, V, Strindfors, G, Tutschek, B, Vangen, S, Weichert, A, Weizsacker, K, Chantraine, F, Is, AIP
Přispěvatelé: Obstetrics & Gynecology, Obstetrics and Gynaecology, University of Helsinki, Department of Obstetrics and Gynecology, HUS Gynecology and Obstetrics, University of Oxford [Oxford], Karolinska University Hospital [Stockholm], Erasmus University Medical Center [Rotterdam] (Erasmus MC), Imagerie Adaptative Diagnostique et Interventionnelle (IADI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service d'Obstétrique et de Gynécologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Freie Universität Berlin, Humboldt-Universität zu Berlin, Charles University [Prague] (CU), Maternité Port-Royal [CHU Cochin], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Copenhagen = Københavns Universitet (KU), Service de Gynécologie-Obstétrique [CHU Trousseau], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Service de Gynécologie et Obstétrique [Cochin], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Università degli studi di Napoli Federico II, Cliniques Universitaires Saint-Luc [Bruxelles], Medizinische Universität Wien = Medical University of Vienna, Centre Hospitalier Universitaire de Liège (CHU-Liège), University Medical Center [Utrecht], Poznan University of Medical Sciences [Poland] (PUMS), Hôpital Pellegrin, CHU Bordeaux [Bordeaux]-Groupe hospitalier Pellegrin, Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], Institute of Clinical Medicine [Oslo], Faculty of Medicine [Oslo], University of Oslo (UiO)-University of Oslo (UiO), Collins, S. L., Alemdar, B., van Beekhuizen, H. J., Bertholdt, C., Braun, T., Calda, P., Delorme, P., Duvekot, J. J., Gronbeck, L., Kayem, G., Langhoff-Roos, J., Marcellin, L., Martinelli, P., Morel, O., Mhallem, M., Morlando, M., Noergaard, L. N., Nonnenmacher, A., Pateisky, P., Petit, P., Rijken, M. J., Ropacka-Lesiak, M., Schlembach, D., Sentilhes, L., Stefanovic, V., Strindfors, G., Tutschek, B., Vangen, S., Weichert, A., Weizsacker, K., Chantraine, F., Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Service d'obstétrique
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Delphi Technique
Placenta
medicine.medical_treatment
increta
Guideline
Oxytocin
Conservative Treatment
placenta accreta spectrum
0302 clinical medicine
PERIPARTUM HYSTERECTOMY
Uterine artery embolization
3123 Gynaecology and paediatrics
Adrenal Cortex Hormones
Pregnancy
030202 anesthesiology
Abnormally invasive placenta
Oxytocics
Obstetrics and Gynaecology
Medicine
030212 general & internal medicine
Non-U.S. Gov't
ComputingMilieux_MISCELLANEOUS
reproductive and urinary physiology
accreta
030219 obstetrics & reproductive medicine
medicine.diagnostic_test
Obstetrics
Mortality rate
Research Support
Non-U.S. Gov't
Obstetrics and Gynecology
Gestational age
Disease Management
Morbidly adherent placenta
3. Good health
Hospitalization
medicine.anatomical_structure
Practice Guideline
SURGICAL-MANAGEMENT
Female
Stents
guideline
CESAREAN-SECTION
SEVERE POSTPARTUM HEMORRHAGE
medicine.medical_specialty
Evidence-based practice
placenta
Placenta Accreta/therapy
Accreta
Gestational Age
[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine
Placenta Accreta
Adrenal Cortex Hormones/therapeutic use
Research Support
Hysterectomy
Patient Positioning
03 medical and health sciences
FIGO CONSENSUS GUIDELINES
abnormally invasive placenta
[INFO.INFO-IM]Computer Science [cs]/Medical Imaging
BAKRI BALLOON TAMPONADE
Journal Article
Humans
Intensive care medicine
Watchful Waiting
Oxytocics/therapeutic use
morbidly adherent placenta
Postpartum Hemorrhage/prevention & control
UTERINE ARTERY EMBOLIZATION
Increta
Cesarean Section
business.industry
Postpartum Hemorrhage
Balloon catheter
Cystoscopy
SUBSEQUENT PREGNANCIES
percreta
Percreta
HYSTEROSCOPIC RESECTION
Ureter
Oxytocin/therapeutic use
business
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
CONSERVATIVE MANAGEMENT
Zdroj: American Journal of Obstetrics and Gynecology, 220(6), 511. Mosby Inc.
American Journal of Obstetrics and Gynecology, 220(6), 511-526. Mosby Inc.
American journal of obstetrics and gynecology, 220(6), 511-526. Mosby Inc.
American Journal of Obstetrics and Gynecology
American Journal of Obstetrics and Gynecology, Elsevier, 2019, 220 (6), pp.511-526. ⟨10.1016/j.ajog.2019.02.054⟩
American Journal of Obstetrics and Gynecology, Vol. 220, no.6, p. 511-526 (2019)
ISSN: 0002-9378
1097-6868
Popis: The worldwide incidence of abnormally invasive placenta is rapidly rising, following the trend of increasing cesarean delivery. It is a heterogeneous condition and has a high maternal morbidity and mortality rate, presenting specific intrapartum challenges. Its rarity makes developing individual expertise difficult for the majority of clinicians. The International Society for Abnormally Invasive Placenta aims to improve clinicians’ understanding and skills in managing this difficult condition. By pooling knowledge, experience, and expertise gained within a variety of different healthcare systems, the Society seeks to improve the outcomes for women with abnormally invasive placenta globally. The recommendations presented herewith were reached using a modified Delphi technique and are based on the best available evidence. The evidence base for each is presented using a formal grading system. The topics chosen address the most pertinent questions regarding intrapartum management of abnormally invasive placenta with respect to clinically relevant outcomes, including the following: definition of a center of excellence; requirement for antenatal hospitalization; antenatal optimization of hemoglobin; gestational age for delivery; antenatal corticosteroid administration; use of preoperative cystoscopy, ureteric stents, and prophylactic pelvic arterial balloon catheters; maternal position for surgery; type of skin incision; position of the uterine incision; use of interoperative ultrasound; prophylactic administration of oxytocin; optimal method for intraoperative diagnosis; use of expectant management; adjuvant therapies for expectant management; use of local surgical resection; type of hysterectomy; use of delayed hysterectomy; intraoperative measures to treat life-threatening hemorrhage; and fertility after conservative management.
Databáze: OpenAIRE
Externí odkaz: